Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Sponsor: University Health Network, Toronto
Summary
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)? Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.
Official title: Thermo-Ablation With Radiofrequency Medical Technologies to Treat Thyroid Cancers
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-04-20
Completion Date
2025-12-31
Last Updated
2025-04-16
Healthy Volunteers
Yes
Conditions
Interventions
Radiofrequency ablation
Radiofrequency energy is delivered to the thyroid nodule via the medical device. This device is a system consisting of 3 main components: 1. VIVA combo RF system (generator and pump) 2. single foot switch 3. electrode (5mm, 7mm, 10mm, or adjustable).
Locations (1)
University Health Network
Toronto, Ontario, Canada